Improved physiological properties of gravity-enforced reassembled rat and human pancreatic pseudo-islets.
Journal article

Improved physiological properties of gravity-enforced reassembled rat and human pancreatic pseudo-islets.

  • Zuellig RA Division of Endocrinology, Diabetes and Clinical Nutrition, University Hospital Zurich, Switzerland.
  • Cavallari G Nephrology, Dialysis and Transplantation Unit (Stefoni), S.Orsola-Malpighi Hospital, University of Bologna, Italy.
  • Gerber P Division of Endocrinology, Diabetes and Clinical Nutrition, University Hospital Zurich, Switzerland.
  • Tschopp O Division of Endocrinology, Diabetes and Clinical Nutrition, University Hospital Zurich, Switzerland.
  • Spinas GA Division of Endocrinology, Diabetes and Clinical Nutrition, University Hospital Zurich, Switzerland.
  • Moritz W InSphero AG, Schlieren, Switzerland.
  • Lehmann R Division of Endocrinology, Diabetes and Clinical Nutrition, University Hospital Zurich, Switzerland.
Show more…
  • 2014-04-17
Published in:
  • Journal of tissue engineering and regenerative medicine. - 2017
English Previously we demonstrated the superiority of small islets vs large islets in terms of function and survival after transplantation, and we generated reaggregated rat islets (pseudo-islets) of standardized small dimensions by the hanging-drop culture method (HDCM). The aim of this study was to generate human pseudo-islets by HDCM and to evaluate and compare the physiological properties of rat and human pseudo-islets. Isolated rat and human islets were dissociated into single cells and incubated for 6-14 days by HDCM. Newly formed pseudo-islets were analysed for dimensions, morphology, glucose-stimulated insulin secretion (GSIS) and total insulin content. The morphology of reaggregated human islets was similar to that of native islets, while rat pseudo-islets had a reduced content of α and δ cells. GSIS of small rat and human pseudo-islets (250 cells) was increased up to 4.0-fold (p < 0.01) and 2.5-fold (p < 0.001), respectively, when compared to their native counterparts. Human pseudo-islets showed a more pronounced first-phase insulin secretion as compared to intact islets. GSIS was inversely correlated to islet size, and small islets (250 cells) contained up to six-fold more insulin/cell than large islets (1500 cells). Tissue loss with this new technology could be reduced to 49.2 ± 1.5% in rat islets, as compared to the starting amount. With HDCM, pseudo-islets of standardized size with similar cellular composition and improved biological function can be generated, which compensates for tissue loss during production. Transplantation of small pseudo-islets may represent an attractive strategy to improve graft survival and function, due to better oxygen and nutrient supply during the phase of revascularization. Copyright © 2014 John Wiley & Sons, Ltd.
Language
  • English
Open access status
closed
Identifiers
Persistent URL
https://folia.unifr.ch/global/documents/107295
Statistics

Document views: 21 File downloads: